| GC32025-100mg |
|
1232861-58-3 |
|
0 |
C36H37F2NO5 |
|
|
|
| GC32025-50mg |
|
1232861-58-3 |
|
0 |
C36H37F2NO5 |
|
|
|
| GC32025-25mg |
|
1232861-58-3 |
|
0 |
C36H37F2NO5 |
|
|
|
| GC32025-10mg |
|
1232861-58-3 |
|
0 |
C36H37F2NO5 |
|
|
|
| GC32025-5mg |
|
1232861-58-3 |
|
0 |
C36H37F2NO5 |
|
|
|
| GC32024-20mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 |
C25H36ClN3O3 |
|
|
|
| GC32024-10mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 |
C25H36ClN3O3 |
|
|
|
| GC32024-5mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 |
C25H36ClN3O3 |
|
|
|
| GC32024-1mg |
|
793674-76-7 |
Itch-Targeting Compound 1
|
0 |
C25H36ClN3O3 |
|
|
|
| GC32023-10mg |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 |
C14H21N5O2S |
|
|
|
| GC32023-5mg |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 |
C14H21N5O2S |
|
|
|
| GC32023-10mM(1mLinDMSO) |
|
1622902-68-4 |
Abrocitinib (PF-04965842)
|
0 |
C14H21N5O2S |
|
|
|
| GC32022-20mg |
|
87549-36-8 |
|
0 |
C17H15NO5 |
|
|
|
| GC32022-10mg |
|
87549-36-8 |
|
0 |
C17H15NO5 |
|
|
|
| GC32022-5mg |
|
87549-36-8 |
|
0 |
C17H15NO5 |
|
|
|
| GC32022-1mg |
|
87549-36-8 |
|
0 |
C17H15NO5 |
|
|
|
| GC32021-20mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 |
C10H11ClN2O2 |
|
|
|
| GC32021-10mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 |
C10H11ClN2O2 |
|
|
|
| GC32021-5mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 |
C10H11ClN2O2 |
|
|
|
| GC32021-1mg |
|
3567-76-8 |
Aminochlorthenoxazin (ICI 350)
|
0 |
C10H11ClN2O2 |
|
|
|
